Get the Stockscreener App
70.76
0.71%
0.50
Pre-market:
70.80
0.04
+0.06%
Dexcom Inc stock is traded at $70.76, with a volume of 5.08M.
It is up +0.71% in the last 24 hours and down -15.63% over the past month.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$70.26
Open:
$71.18
24h Volume:
5.08M
Relative Volume:
1.46
Market Cap:
$28.36B
Revenue:
$4.03B
Net Income/Loss:
$576.20M
P/E Ratio:
49.48
EPS:
1.43
Net Cash Flow:
$630.70M
1W Performance:
-13.67%
1M Performance:
-15.63%
6M Performance:
+2.82%
1Y Performance:
-47.73%
1-Day Range:
$69.86
$72.30
1-Week Range:
$69.02
$81.75
52-Week Range:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
70.76 | 28.36B | 4.03B | 576.20M | 630.70M | 1.43 |
|
ABT
Abbott Laboratories
|
130.28 | 225.95B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.42 | 142.29B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.84 | 138.83B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.51 | 117.34B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.51 | 40.28B | 5.72B | 4.17B | 259.90M | 6.97 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
Non-Invasive Blood Glucose Monitoring Devices Market Is Booming Worldwide 2025-2032:Dexcom, Inc,Opticology - EIN News
Head to Head Contrast: DexCom (NASDAQ:DXCM) vs. Biotricity (NASDAQ:BTCY) - Defense World
Dexcom’s CFO Sylvain sells shares worth $516,830 - Investing.com
Is DexCom Stock Underperforming The Dow? - Barchart
DexCom Options Trading: A Deep Dive into Market Sentiment - Benzinga
SBI Securities Co. Ltd. Makes New Investment in DexCom, Inc. (NASDAQ:DXCM) - Defense World
DexCom continues decline following FDA warning letter - MSN
DexCom Inc. stock underperforms Monday when compared to competitors - MarketWatch
Dexcom receives warning letter based on FDA inspections of 2 plants - MedTech Dive
DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter - Investopedia
DexCom, Inc. Appoints Renée Galá as A Director -March 10, 2025 at 08:31 am EDT - Marketscreener.com
DexCom adds Renée Galá to Board of Directors By Investing.com - Investing.com South Africa
DexCom adds Renée Galá to Board of Directors - Investing.com
Dexcom Appoints Renée Galá to Board of Directors - StockTitan
DexCom's SWOT analysis: stock faces challenges amid growth potential - MSN
DexCom falls after warning letter from FDA related to quality concerns - MSN
Finding Dexcom monitors amid shortages - MSN
Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now? - Insider Monkey
Dexcom receives FDA warning letter - Mass Device
Dexcom receives FDA warning letter for two U.S. manufacturing facilities - Reuters.com
Dexcom Inc Does Not Expect Material Impact From FDA Warning Letter -March 07, 2025 at 05:03 pm EST - Marketscreener.com
DexCom Receives US FDA Warning After Inspections -March 07, 2025 at 04:59 pm EST - Marketscreener.com
DexCom receives warning letter from FDA, sees no impact to FY25 guidance - TipRanks
DexCom Stock Price | DXCM Stock Quote, News, and History - Markets Insider
Investigation announced for Long-Term Investors in DexCom, - openPR
What Is DexCom, Inc.'s (NASDAQ:DXCM) Share Price Doing? - Simply Wall St
Citigroup Issues Positive Forecast for DexCom (NASDAQ:DXCM) Stock Price - Defense World
DexCom, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by DexCom (DXCM) - ACCESS Newswire
DexCom: Valuation Does Not Factor In Slowing Growth (NASDAQ:DXCM) - Seeking Alpha
Is DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 27% Impressive? - Yahoo Finance
Jefferies Adjusts Price Target on DexCom to $105 From $100, Keeps Buy Rating -March 04, 2025 at 06:14 am EST - Marketscreener.com
Citigroup Adjusts Price Target on DexCom to $104 From $101, Maintains Buy Rating -March 04, 2025 at 05:53 am EST - Marketscreener.com
Wearable Patch Market Growth in Future Scope 2025-2032 | Dexcom, Inc., GENTAG, Inc., Abbott Laboratories - openPR
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
DexCom (DXCM) Accused of Misleading InvestorsHagens Berman - ACCESS Newswire
26,263 Shares in DexCom, Inc. (NASDAQ:DXCM) Bought by First American Bank - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Stake Decreased by Taylor Frigon Capital Management LLC - MarketBeat
Y Intercept Hong Kong Ltd Sells 47,164 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Amalgamated Bank Sells 3,208 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Purchased by Brown Financial Advisors - MarketBeat
Union Bancaire Privee UBP SA Makes New Investment in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Sanctuary Advisors LLC Raises Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Shareholders That Lost Money on DexCom, Inc. (DXCM) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Shareholders That Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class ActionDXCM - ACCESS Newswire
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM) - Barchart
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by National Pension Service - MarketBeat
Private Advisor Group LLC Acquires 3,831 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):